/OSCR
OSCR Stock - Oscar Health, Inc.
Healthcare|Medical - Healthcare PlansNYSE
$14.90+0.68%
+$0.10 (+0.68%) • Dec 19
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.25
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).58
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.45
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+4.0%upside
Target: $15.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OSCR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$14.75 – $15.05
TARGET (TP)$15.50
STOP LOSS$13.71
RISK/REWARD1:0.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.88
52W High$23.80
52W Low$11.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $9.18B | $5.86B | $4.13B | $1.92B | $589.64M |
| Gross Profit | $9.18B | $5.86B | $4.13B | $1.92B | $589.64M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $33.43M | $-267,300,000 | $-610,075,000 | $-570,580,000 | $-405,780,000 |
| Net Income | $25.43M | $-270,728,000 | $-606,275,000 | $-572,606,000 | $-406,825,000 |
| Net Margin | 0.3% | -4.6% | -14.7% | -29.8% | -69.0% |
| EPS | $0.11 | $-1.22 | $-2.87 | $-3.19 | $-1.70 |
Company Overview
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
18%
Hold / Neutral
10
59%
Sell / Underperform
4
24%
Analyst Consensus🔴 Bearish
3 Bullish14 Neutral/Bearish
Price Targets
$15
Average Target
↓ 2.2% Downside
Now
$4
Low
$15
Average
$28
High
Based on 22 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 11th 2025 | Stephens | Initiation | Equal Weight | $17 |
| November 26th 2025 | Piper Sandler | Upgrade | Overweight | $25 |
| October 14th 2025 | Goldman | Initiation | Neutral | $17 |
| July 25th 2025 | Robert W. Baird | Downgrade | Neutral | $14 |
| July 15th 2025 | UBS | Downgrade | Sell | $11 |
| July 14th 2025 | Piper Sandler | Downgrade | Neutral | $14 |
| July 11th 2025 | Wells Fargo | Downgrade | Underweight | $10 |
| July 2nd 2025 | Barclays | Initiation | Underweight | $17 |
| June 24th 2025 | Raymond James | Downgrade | Market Perform | - |
| March 13th 2025 | Wells Fargo | Downgrade | Equal Weight | $16← $20 |
| December 10th 2024 | Jefferies | Initiation | Underperform | $12 |
| November 6th 2024 | BofA Securities | Downgrade | Underperform | $13.5← $21 |
| October 7th 2024 | UBS | Initiation | Neutral | $23 |
| June 26th 2024 | Piper Sandler | Initiation | Overweight | $25 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $28 |
Earnings History & Surprises
OSCRBeat Rate
67%
Last 18 quarters
Avg Surprise
+1.0%
EPS vs Estimate
Beats / Misses
12/6
Last 12 quarters
Latest EPS
$-0.53
Q4 2025
EPS Surprise History
Q1 24
+10.8%
$-0.66vs$-0.74
Q2 24
+129.6%
$0.62vs$0.27
Q3 24
+25.0%
$0.20vs$0.16
Q4 24
-10.0%
$-0.22vs$-0.20
Q1 25
-12.7%
$-0.62vs$-0.55
Q2 25
+10.8%
$0.92vs$0.83
Q3 25
+1.1%
$-0.89vs$-0.90
Q4 25
+3.6%
$-0.53vs$-0.55
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | $-0.84 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.55 | $-0.53 | +3.6% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $-0.90 | $-0.89 | +1.1% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $0.83 | $0.92 | +10.8% | ✓ BEAT |
Q1 2025 | Feb 4, 2025 | $-0.55 | $-0.62 | -12.7% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $-0.20 | $-0.22 | -10.0% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $0.16 | $0.20 | +25.0% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.27 | $0.62 | +129.6% | ✓ BEAT |
Q1 2024 | Feb 7, 2024 | $-0.74 | $-0.66 | +10.8% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $-0.47 | $-0.29 | +38.3% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $-0.33 | $-0.07 | +78.8% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $-0.05 | $-0.18 | -254.7% | ✗ MISS |
Q1 2023 | Feb 9, 2023 | $-1.01 | $-1.05 | -4.0% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $-0.76 | $-0.91 | -19.7% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.73 | $-0.53 | +27.4% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $-0.40 | $-0.36 | +10.0% | ✓ BEAT |
Q1 2022 | Feb 10, 2022 | $-1.03 | $-0.95 | +7.8% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $-0.68 | $-1.02 | -50.0% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-0.47 | $-0.35 | +25.5% | ✓ BEAT |
Latest News
President Trump Says We Could Get Insurance Companies To Cut Prices To Stay In System; I Will Call Meeting Of Insurance Companies To Get Their Price Down; Meeting In Coming Weeks
📈 PositiveBenzinga•Dec 19, 2025, 08:03 PM•Also: , ,
Stephens & Co. Initiates Coverage On Oscar Health with Equal-Weight Rating, Announces Price Target of $17
➖ NeutralBenzinga•Dec 11, 2025, 09:46 AM
Oscar Health shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $13 to $25.
📈 PositiveBenzinga•Nov 26, 2025, 04:07 PM
Piper Sandler Upgrades Oscar Health to Overweight, Raises Price Target to $25
📈 PositiveBenzinga•Nov 26, 2025, 01:04 PM
Reuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeBenzinga•Nov 24, 2025, 07:22 PM•Also: , ,
Shares of healthcare stocks are trading higher after Politico reported the White House will propose a two-year extension of Obamacare subsidies with new limits on eligibility.
📈 PositiveBenzinga•Nov 24, 2025, 01:00 PM•Also: , ,
Market-Moving News for November 24th
➖ NeutralBenzinga•Nov 24, 2025, 12:41 PM•Also: ,
Politico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility
➖ NeutralBenzinga•Nov 24, 2025, 11:16 AM•Also: , ,
Oscar Health shares are trading lower after Wells Fargo maintained an Underweight rating on the stock and lowered its price target from $14 to $11.
📉 NegativeBenzinga•Nov 13, 2025, 05:32 PM
Wells Fargo Maintains Underweight on Oscar Health, Lowers Price Target to $11
📉 NegativeBenzinga•Nov 13, 2025, 03:41 PM
Barclays Maintains Underweight on Oscar Health, Raises Price Target to $13
➖ NeutralBenzinga•Nov 10, 2025, 06:54 PM•Also:
Oscar Health Expands Affordable, Tech-Powered Plans Across South Florida For 2026 Enrollment
📈 PositiveBenzinga•Nov 10, 2025, 11:06 AM
UBS Maintains Sell on Oscar Health, Raises Price Target to $12
➖ NeutralBenzinga•Nov 7, 2025, 05:45 PM•Also:
OSCR stock has given up its prior gain. Oscar Health shares were trading higher after the company beat Q3 earnings estimates.
📉 NegativeBenzinga•Nov 6, 2025, 08:55 PM
Oscar Health shares are trading higher after the company beat Q3 earnings estimates.
📈 PositiveBenzinga•Nov 6, 2025, 11:19 AM
Oscar Health Affirms FY2025 Sales Guidance of $12.000B-$12.200B vs $12.039B Est
➖ NeutralBenzinga•Nov 6, 2025, 11:02 AM
Oscar Health Q3 EPS $(0.53) Beats $(0.61) Estimate, Sales $2.986B Miss $3.082B Estimate
➖ NeutralBenzinga•Nov 6, 2025, 11:01 AM
Oscar Health Rolling Out Different Health Plans For Individuals, Families, Businesses Throughout Orlando
📈 PositiveBenzinga•Nov 5, 2025, 03:58 PM
Oscar Health shares are trading higher. The company recently introduced a suite of easy-to-use health plans and AI features for millions of people for 2026 open enrollment.
📈 PositiveBenzinga•Oct 21, 2025, 05:14 PM
Oscar Health Is Introducing A Suite Of Easy-to-use Health Plans And AI Features For Millions Of People For 2026 Open Enrollment
📈 PositiveBenzinga•Oct 20, 2025, 10:05 AM
Frequently Asked Questions about OSCR
What is OSCR's current stock price?
Oscar Health, Inc. (OSCR) is currently trading at $14.90 per share. The stock has moved +0.68% today.
What is the analyst price target for OSCR?
The average analyst price target for OSCR is $15.50, based on 1 analyst.
What sector is Oscar Health, Inc. in?
Oscar Health, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the NYSE exchange.
What is OSCR's market cap?
Oscar Health, Inc. has a market capitalization of $3.81 billion, making it a mid-cap company.
Does OSCR pay dividends?
No, Oscar Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACLX
Arcellx, Inc.
$63.96
Mkt Cap: $3.5B
AKRO
Akero Therapeutics, Inc.
$54.65
Mkt Cap: $4.5B
ALHC
Alignment Healthcare, Inc.
$20.42
Mkt Cap: $4.1B
HNGE
Hinge Health, Inc.
$47.25
Mkt Cap: $3.7B
IMVT
Immunovant, Inc.
$26.68
Mkt Cap: $4.7B
KYMR
Kymera Therapeutics, Inc.
$83.99
Mkt Cap: $6.0B
NAMS
NewAmsterdam Pharma Company N.V.
$35.11
Mkt Cap: $4.0B
OPCH
Option Care Health, Inc.
$32.51
Mkt Cap: $5.4B
TMDX
TransMedics Group, Inc.
$127.67
Mkt Cap: $4.4B
VKTX
Viking Therapeutics, Inc.
$35.19
Mkt Cap: $4.0B
Explore stocks similar to OSCR for comparison